Arrayit Corporation Receives Contract Award From the Department of Veterans Affairs
October 31 2013 - 1:46PM
Arrayit Corporation (OTCBB:ARYC), a life sciences and molecular
diagnostics leader, announces today a $39,590 contract award from
the United States Department of Veteran Affairs (VA). The VA
Healthcare System provides some of the world's finest medicine and
cutting-edge technology, as well as a teaching hospital, a full
range of patient care services and research in the areas of
medicine, surgery, psychiatry, rehabilitation, neurology, oncology,
dentistry, geriatrics, and extended care.
The Veteran Affairs Hospital purchased the Arrayit Colorimetric
Protein Microarray Platform I, which includes a microarray printer,
microarray scanner, tools, kits, reagents and consumables for rapid
and affordable protein microarray experimentation. Arrayit
protein microarray technology empowers the Veterans
Administration's mission of advanced research in geriatrics, mental
health, Alzheimer's disease, spinal cord regeneration,
schizophrenia, rehabilitation, HIV research, health economics, and
other areas critical to our veterans.
Arrayit's tagline "Powerful Science for Life" is consistent with
the VA mission statement of fulfilling President Abraham Lincoln's
promise "To care for him who shall have borne the battle, and for
his widow, and his orphan" by serving and honoring the men and
women who are America's veterans. ARYC will fulfill the
contract during the fourth quarter of this year.
About Arrayit Corporation
Arrayit utilizes its patented and proprietary microarray
platform to lead and empower the genetic, research, pharmaceutical,
and diagnostic communities through the discovery, development and
manufacture of proprietary life science technologies and
consumables for disease prevention, treatment and cure.
- Powerful Science for Life
Visit http://arrayit.com/ for more information.
Safe Harbor Statement
We have identified forward-looking statements by using words
such as "expect", "believe", and "should". Although we believe our
expectations are reasonable, our operations involve a number of
risks and uncertainties that are beyond our control, and these
statements may turn out not to be true. Risk factors associated
with our business, including some of the facts set forth herein,
are detailed in the Company's Form 10-K for the fiscal year ended
December 31, 2012 and in Form 10-Q for the quarterly period ended
June 30, 2013.
CONTACT: Media Contact
John Nesbett
Institutional Marketing Services
203.972.9200
JNesbett@InstitutionalMS.com
Arrayit (CE) (USOTC:ARYC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Arrayit (CE) (USOTC:ARYC)
Historical Stock Chart
From Apr 2023 to Apr 2024